• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Metropolis Share Price

    Metropolis Healthcare Share PriceMetropolis Healthcare

    Mid Cap 11k Result
    ₹1,702.95
    12.95 (0.77%)
    As on 30 November, 2023 | 11:19 BSE: 542650 NSE: METROPOLISISIN: INE112L01020

    Metropolis Healthcare Performance

    Day Range

    • Low 1,688.45
    • High 1,709.50
    ₹ 1,702.95

    52 Week Range

    • Low 1,171.35
    • High 1,711.50
    ₹ 1,702.95
    • Open Price1,704.25
    • Previous Close1,690.00
    • Volume130518

    Start SIP in Metropolis Healthcare

    Start SIP

    Metropolis Healthcare Share Price

    • Over 1 Month 23.27%
    • Over 3 Month 27.74%
    • Over 6 Month 30.66%
    • Over 1 Year 15.61%

    Metropolis Healthcare Key Statistics

    P/E Ratio 65.4
    PEG Ratio -4.7
    Market Cap Cr 8,723
    Price to Book Ratio 8.8
    EPS 27.1
    Dividend 0.7
    Relative Strength Index 69.92
    Money Flow Index 83.93
    MACD Signal 43.24
    Average True Range 45.87

    Metropolis Healthcare F&O

    Metropolis Healthcare Futures
    Metropolis Healthcare Option Chain

    Metropolis Healthcare Investment Rating

    • Master Rating:

    • Metropolis Healthcare has an operating revenue of Rs. 1,153.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 16% is great, ROE of 14% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 21% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Metropolis Healthcare Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 285256264265280257218
    Operating Expenses Qtr Cr 218198197199205196172
    Operating Profit Qtr Cr 67586866756146
    Depreciation Qtr Cr 21202222202012
    Interest Qtr Cr 6666785
    Tax Qtr Cr 11981213710
    Net Profit Qtr Cr 31264033382863
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,0871,133
    Operating Expenses Annual Cr 797812
    Operating Profit Annual in Cr 269305
    Depreciation Cr 8556
    Interest Annual Cr 2719
    Tax Annual Cr 4070
    Net Profit Annual Cr 139192
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 238237
    Cash from Investing Activity Annual Cr 47-734
    Cash from Financing Annual Activity Cr -288173
    Net Cash Flow Annual Cr -3-323
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 936824
    Fixed Assets Annual Cr 1,085320
    Total Non Current Assets Annual Cr 1,1691,005
    Total Current Assets Annual Cr 265340
    Total Assets Annual Cr 1,4341,345
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 183161
    ROE Annual % 1523
    ROCE Annual % 1725
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2729
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 309277283285300280306
    Operating Expenses Qtr Cr 234214212215221211231
    Operating Profit Qtr Cr 75637070796875
    Depreciation Qtr Cr 22212323222118
    Interest Qtr Cr 6666786
    Tax Qtr Cr 121081214916
    Net Profit Qtr Cr 35293336403340
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,1631,246
    Operating Expenses Annual Cr 860886
    Operating Profit Annual in Cr 288343
    Depreciation Cr 8963
    Interest Annual Cr 2720
    Tax Annual Cr 4479
    Net Profit Annual Cr 143214
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 247253
    Cash from Investing Activity Annual Cr 47-738
    Cash from Financing Annual Activity Cr -292163
    Net Cash Flow Annual Cr 2-322
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 988888
    Fixed Assets Annual Cr 685610
    Total Non Current Assets Annual Cr 1,1991,137
    Total Current Assets Annual Cr 303393
    Total Assets Annual Cr 1,5021,530
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 193174
    ROE Annual % 1424
    ROCE Annual % 1724
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2629
    Invest in Metropolis Healthcare

    Metropolis Healthcare Technicals

    EMA & SMA

    Current Price
    ₹1,702.95
    12.95 (0.77%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹1,599.11
    • 50 Day
    • ₹1,529.94
    • 100 Day
    • ₹1,473.90
    • 200 Day
    • ₹1,454.92
    • 20 Day
    • ₹1,590.48
    • 50 Day
    • ₹1,514.35
    • 100 Day
    • ₹1,454.40
    • 200 Day
    • ₹1,378.49

    Metropolis Healthcare Resistance and Support

    PIVOT
    ₹1,693.09
    Resistance
    First Resistance 1,708.42
    Second Resistance 1,726.83
    Third Resistance 1,742.17
    RSI 69.92
    MFI 83.93
    MACD Single Line 43.24
    MACD 49.11
    Support
    First Resistance 1,674.67
    Second Resistance 1,659.33
    Third Resistance 1,640.92

    Metropolis Healthcare Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 290,219 10,970,278 37.8
    Week 352,482 13,915,970 39.48
    1 Month 406,446 12,685,190 31.21
    6 Month 375,501 12,004,778 31.97

    Metropolis Healthcare Result Highlights

    Metropolis Healthcare Synopsis

    NSE-Medical-Services

    Metropolis Healthcar is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1066.04 Cr. and Equity Capital is Rs. 10.24 Cr. for the Year ended 31/03/2023. Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798.
    Market Cap 8,657
    Sales 1,071
    Shares in Float 2.56
    No of funds 172
    Yield 0.71
    Book Value 9.25
    U/D Vol ratio 2
    LTDebt / Equity 3
    Alpha 0.05
    Beta 0.89

    Metropolis Healthcare

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 49.74%49.75%49.75%49.76%
    Mutual Funds 14.02%13.34%12.38%11.79%
    Insurance Companies 2.4%1.13%0.94%0.94%
    Foreign Portfolio Investors 24.29%25.66%25.67%23.86%
    Individual Investors 7.78%8.15%8.53%9.74%
    Others 1.77%1.97%2.73%3.91%

    Metropolis Healthcare Management

    Name Designation
    Dr. Sushil Kanubhai Shah Chairman & Executive Director
    Mrs. Ameera Sushil Shah Managing Director
    Mr. Hemant Sachdev Non Exe.Non Ind.Director
    Mr. Vivek Gambhir Ind. Non-Executive Director
    Mr. Sanjay Bhatnagar Ind. Non-Executive Director
    Mr. Milind Shripad Sarwate Ind. Non-Executive Director
    Ms. Anita Ramachandran Ind. Non-Executive Director

    Metropolis Healthcare Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Metropolis Healthcare Corporate Action

    Date Purpose Remarks
    2023-11-04 Quarterly Results & Interim Dividend
    2023-08-02 Quarterly Results
    2023-05-16 Audited Results
    2023-02-10 Quarterly Results & Interim Dividend
    2022-11-08 Quarterly Results
    Date Purpose Remarks
    2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
    2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
    2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
    2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

    Metropolis Healthcare MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 37,319
    Kotak Equity Arbitrage Fund Growth 28,958
    UTI Flexi Cap Fund Regular Plan Growth 24,370
    SBI Arbitrage Opportunities Fund Regular Growth 22,370
    Aditya Birla Sun Life Flexi Cap Fund Growth 17,029

    Metropolis Healthcare FAQs

    What is Share Price of Metropolis Healthcare ?

    Metropolis Healthcare share price is ₹1,702 As on 30 November, 2023 | 11:05

    What is the Market Cap of Metropolis Healthcare ?

    The Market Cap of Metropolis Healthcare is ₹8723.1 Cr As on 30 November, 2023 | 11:05

    What is the P/E ratio of Metropolis Healthcare ?

    The P/E ratio of Metropolis Healthcare is 65.4 As on 30 November, 2023 | 11:05

    What is the PB ratio of Metropolis Healthcare ?

    The PB ratio of Metropolis Healthcare is 8.8 As on 30 November, 2023 | 11:05

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.